Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2−metastatic breast cancer receiving single-agent chemotherapy—a comparison with MONARCH 1
Titel:
Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2−metastatic breast cancer receiving single-agent chemotherapy—a comparison with MONARCH 1
Auteur:
Rugo, Hope S. Dieras, Veronique Cortes, Javier Patt, Debra Wildiers, Hans O’Shaughnessy, Joyce Zamora, Esther Yardley, Denise A. Carter, Gebra Cuyun Sheffield, Kristin M. Li, Li Andre, Valerie A. M. Li, Xiaohong I. Frenzel, Martin Huang, Yu-Jing Dickler, Maura N. Tolaney, Sara M.